Abstract / Description of output
To test the genetic contribution of rare missense variants in COL4A1 and COL4A2 in
which common variants are genetically associated with sporadic intracerebral
hemorrhage (ICH), we performed rare variant analysis in multiple sequencing data for the
risk for sporadic ICH.
Methods
We performed sequencing across 559Kbp at 13q34 including COL4A1 and COL4A2
among 2,133 individuals (1,055 ICH cases; 1,078 controls) in US-based and 1,492
individuals (192 ICH cases; 1,189 controls) from Scotland-based cohorts, followed by
sequence annotation, functional impact prediction, genetic association testing, and in
silico thermodynamic modeling.
Results
We identified 107 rare nonsynonymous variants in sporadic ICH, of which two missense
variants, rs138269346 (COL4A1I110T) and rs201716258 (COL4A2H203L), were predicted
to be highly functional and occurred in multiple ICH cases but not in controls from the
US-based cohort. The minor allele of rs201716258 was also present in Scottish ICH
patients, and rs138269346 was observed in two ICH-free controls with a history of
hypertension and myocardial infarction. Rs138269346 was nominally associated with
non-lobar ICH risk (P=0.05), but not with lobar ICH (P=0.08), while associations
between rs201716258 and ICH subtypes were non-significant (P>0.12). Both variants
were considered pathogenic based on minor allele frequency (<0.00035 in EUR), predicted functional impact (deleterious or probably damaging), and in silico modeling studies (substantially altered physical length and thermal stability of collagen).
Conclusions
We identified rare missense variants in COL4A1/A2 in association with sporadic ICH.
Our annotation and simulation studies suggest that these variants are highly functional
and may represent targets for translational follow-up.
which common variants are genetically associated with sporadic intracerebral
hemorrhage (ICH), we performed rare variant analysis in multiple sequencing data for the
risk for sporadic ICH.
Methods
We performed sequencing across 559Kbp at 13q34 including COL4A1 and COL4A2
among 2,133 individuals (1,055 ICH cases; 1,078 controls) in US-based and 1,492
individuals (192 ICH cases; 1,189 controls) from Scotland-based cohorts, followed by
sequence annotation, functional impact prediction, genetic association testing, and in
silico thermodynamic modeling.
Results
We identified 107 rare nonsynonymous variants in sporadic ICH, of which two missense
variants, rs138269346 (COL4A1I110T) and rs201716258 (COL4A2H203L), were predicted
to be highly functional and occurred in multiple ICH cases but not in controls from the
US-based cohort. The minor allele of rs201716258 was also present in Scottish ICH
patients, and rs138269346 was observed in two ICH-free controls with a history of
hypertension and myocardial infarction. Rs138269346 was nominally associated with
non-lobar ICH risk (P=0.05), but not with lobar ICH (P=0.08), while associations
between rs201716258 and ICH subtypes were non-significant (P>0.12). Both variants
were considered pathogenic based on minor allele frequency (<0.00035 in EUR), predicted functional impact (deleterious or probably damaging), and in silico modeling studies (substantially altered physical length and thermal stability of collagen).
Conclusions
We identified rare missense variants in COL4A1/A2 in association with sporadic ICH.
Our annotation and simulation studies suggest that these variants are highly functional
and may represent targets for translational follow-up.
Original language | English |
---|---|
Journal | Neurology |
DOIs | |
Publication status | Published - 24 May 2021 |